Nikhil Mutyal
Global Head of Search & Evaluation, Respiratory & Immunology AstraZeneca
Nikhil Mutyal, Ph.D., is Global Head of Search and Evaluation – Respiratory & Immunology at AstraZeneca, where he leads a team focused on R&I BD across all stages, geographies and modalities. A pharmaceutical business development and strategic planning leader, he is passionate about building teams that create value through external innovation and transformative deals, with a knack for identifying “diamonds in the rough.” His work sits at the intersection of science, strategy, and deals, shaping partnerships and driving pipeline impact. He has held BD&L and corporate development roles at Merck, Jazz Pharmaceuticals, and AVEO Oncology.
Seminars
Tuesday 15th September 2026
Pharma & Investor Roundtable Discussions
2:00 pm
- Connect directly with leading experts in an interactive roundtable setting, sharing your work and showcasing your assets in focused, face-to-face conversations
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration
- For biotech, gain actionable insights by hearing what your peers are developing and understand first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
Tuesday 15th September 2026
Panel Discussion: Aligning Pharma Partnership Expectations Across Biotech & Academics to Encourage Successful Collaborations
1:30 pm
- Identifying the ideal development stage for engagement to ensure timely and effective collaboration
- Detailing therapies of interest, considering in vivo and beyond to identify high-value opportunities
- Discussing collaboration processes beyond initial interest to secure
